Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 818

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 818
---
 options under all plans:

| Unvested at June 30, 2023     |     | Number ofOptions(in thousands) | 118 |   |     | Weightedaverageexerciseprice$ | 24.12 |
|:------------------------------|:----|:-------------------------------|----:|:--|:----|:------------------------------|------:|
| Granted                       |     |                                |  89 |   |     |                               |  4.66 |
| Vested                        |     |                                | (40 | ) |     |                               | 19.68 |
| Forfeited                     |     |                                | (31 | ) |     |                               |  8.26 |
| Unvested at December 31, 2023 |     |                                | 136 |   |     |                               | 16.33 |

The aggregate intrinsic value of unvested stock options at December 31, 2023, was nil(2022 - nil). The unvested stock options have a remaining weighted average contractual term of 9.00years (2022 - 9.18).

<div align='center'>F-62</div>

Kintara Therapeutics, Inc. Notes to Condensed Consolidated Interim Financial Statements (Unaudited) December 31, 2023 (expressed in US dollars and in thousands, except par value and per share amounts, unless otherwise noted)

Restricted stock units

During the six months ended December 31, 2023, the Company recognized a total of $ 85(2022 - nil) in compensation expense related to RSUs.

| Balance - June 30, 2023              |     | Number ofRSU(in thousands) | 78 |   |
|:-------------------------------------|:----|:---------------------------|---:|:--|
| Issuance of restricted stock units   |     |                            |  — |   |
| Vesting of restricted stock units    |     |                            | (4 | ) |
| Forfeiture of restricted stock units |     |                            | (8 | ) |
| Balance - December 31, 2023          |     |                            | 66 |   |

Common stock warrants

The following table sets forth changes in outstanding common stock warrants:

| Balance - June 30, 2023                |     | Number ofWarrants(in thousands) | 713 |   |     | Weightedaverageexerciseprice$ | 43.55 |